1 00:00:01,000 --> 00:00:04,000 So, when I first came to town, the Red Sox hadn't won for 42 years. 2 00:00:04,000 --> 00:00:08,000 Now it's been 86 years, so the whole town all of a sudden changes 3 00:00:08,000 --> 00:00:13,000 its psychology. A time for great celebration, 4 00:00:13,000 --> 00:00:17,000 at least for you Red Sox fans. At the, after last lecture I had an 5 00:00:17,000 --> 00:00:21,000 interesting conversation with one of you. One of you came up to me and 6 00:00:21,000 --> 00:00:26,000 said very politely, Professor Weinberg, do you have some 7 00:00:26,000 --> 00:00:30,000 lecture notes that you have written out what the important points of the 8 00:00:30,000 --> 00:00:35,000 lecture are that you could give me or that you could give us? 9 00:00:35,000 --> 00:00:39,000 And I said, you know, I, I'm not really interested in 10 00:00:39,000 --> 00:00:43,000 doing that. And the reason I'm not really interested in doing that is 11 00:00:43,000 --> 00:00:47,000 that the main function of this course is to enable you to listen to, 12 00:00:47,000 --> 00:00:51,000 when somebody is talking about conceptually complex things and to 13 00:00:51,000 --> 00:00:55,000 distil what's being said and to figure out in your own mind what's 14 00:00:55,000 --> 00:00:59,000 important and what is just another piece of drivel coming out of my 15 00:00:59,000 --> 00:01:04,000 mouth or Eric Lander's mouth. In fact, speaking for him, 16 00:01:04,000 --> 00:01:08,000 if I will allow, can allow myself, and myself, in the end we don't 17 00:01:08,000 --> 00:01:12,000 really care that much whether you know the difference between DNA and 18 00:01:12,000 --> 00:01:16,000 RNA or proteins and phospholipids. What we're really interested in 19 00:01:16,000 --> 00:01:20,000 doing is to use this course as a vehicle for pushing you to get your 20 00:01:20,000 --> 00:01:24,000 brains functioning even better than they already are. 21 00:01:24,000 --> 00:01:28,000 And, therefore, if you learn in this course how to, 22 00:01:28,000 --> 00:01:32,000 to think about very complex subjects and figure out what's really going 23 00:01:32,000 --> 00:01:36,000 on then this course will have more than paid for itself in terms of the 24 00:01:36,000 --> 00:01:41,000 energy you put into it. So, that's part of the reason why we 25 00:01:41,000 --> 00:01:46,000 don't provide you with lecture outlines. We want you to figure out 26 00:01:46,000 --> 00:01:51,000 what's important on your own. Being able to do so will itself be 27 00:01:51,000 --> 00:01:55,000 a major triumph. At the end of our discussion last 28 00:01:55,000 --> 00:02:00,000 time we talked about the cell cycle, the fact that it has, has four major 29 00:02:00,000 --> 00:02:05,000 active phases. G1, S, G2 and mitosis. 30 00:02:05,000 --> 00:02:09,000 We talked about mitosis. And we talked about the fact that 31 00:02:09,000 --> 00:02:14,000 when cells emerge from mitosis, from M phase in the absence of 32 00:02:14,000 --> 00:02:18,000 growth stimulatory factors then they go into G zero. 33 00:02:18,000 --> 00:02:23,000 And if they're provided with growth stimulatory factors then they'll go 34 00:02:23,000 --> 00:02:27,000 back into the active cell cycle. And this G zero phase we talked 35 00:02:27,000 --> 00:02:32,000 about is a quiescence phase, it's a resting phase. 36 00:02:32,000 --> 00:02:36,000 In fact, there are two kinds of quiescent cells in our bodies. 37 00:02:36,000 --> 00:02:40,000 Those that go into quiescence, non-growth reversibly, and are able 38 00:02:40,000 --> 00:02:44,000 to reemerge back into the active cell cycle, and those cells which 39 00:02:44,000 --> 00:02:48,000 have irreversibly retreated from the active cell cycle. 40 00:02:48,000 --> 00:02:52,000 So, for example, there are many cells in our brain where no matter 41 00:02:52,000 --> 00:02:56,000 what you do to them they will never be able to go back into the active 42 00:02:56,000 --> 00:03:00,000 cell cycle. And they are, in that sense, considered to be 43 00:03:00,000 --> 00:03:04,000 post-mitotic. Post-mitotic meaning that they will 44 00:03:04,000 --> 00:03:09,000 never again grow. It's really not clear which of the 45 00:03:09,000 --> 00:03:13,000 post-mitotic cells, which tissues in the body harbor, 46 00:03:13,000 --> 00:03:18,000 harbor post-mitotic cells. We used to think that most of the 47 00:03:18,000 --> 00:03:23,000 differentiated cells in our body are post-mitotic. And when I say 48 00:03:23,000 --> 00:03:28,000 differentiated, a topic we will not get into for the 49 00:03:28,000 --> 00:03:33,000 moment, what I mean is that different cells in different parts 50 00:03:33,000 --> 00:03:37,000 of the body have become differentiated by becoming very 51 00:03:37,000 --> 00:03:42,000 specialized to become neurons or becoming liver cells or to becoming 52 00:03:42,000 --> 00:03:46,000 skin cells and so forth. And it is probably the case that 53 00:03:46,000 --> 00:03:50,000 there are many kinds of differentiated cells in the body 54 00:03:50,000 --> 00:03:54,000 which once they differentiate will no longer enter into the active cell 55 00:03:54,000 --> 00:03:58,000 cycle. Now, getting back to this. 56 00:03:58,000 --> 00:04:02,000 As I also mentioned, if we look at a Petri dish then and 57 00:04:02,000 --> 00:04:06,000 we put cells like fibroblast, connective tissue cells in the 58 00:04:06,000 --> 00:04:10,000 bottom of the Petri dish, as I told you last time, if you 59 00:04:10,000 --> 00:04:14,000 provide those cells with medium which contains all the requisite 60 00:04:14,000 --> 00:04:18,000 nutrients, these cells will sit here happily for an extended period of 61 00:04:18,000 --> 00:04:22,000 time but will not proliferate. However, if you add to their serum, 62 00:04:22,000 --> 00:04:26,000 add their medium, you add serum to this medium. Serum usually comes 63 00:04:26,000 --> 00:04:30,000 from cows, so therefore it's called bovine serum. 64 00:04:30,000 --> 00:04:34,000 Then the serum, in addition to the nutrients present 65 00:04:34,000 --> 00:04:39,000 in the, in the medium will indeed provoke these cells to proliferate, 66 00:04:39,000 --> 00:04:43,000 and there are agents in the serum, in fact there are agents which are 67 00:04:43,000 --> 00:04:48,000 called growth factors which are contained within the serum which are 68 00:04:48,000 --> 00:04:53,000 responsible for inducing these, these cells to begin to proliferate. 69 00:04:53,000 --> 00:04:57,000 Well, it's instructive just for a moment to step back and ask 70 00:04:57,000 --> 00:05:01,000 ourselves what actually is serum? How do you get serum? 71 00:05:01,000 --> 00:05:05,000 And the way you get serum is you take blood and you allow it to clot. 72 00:05:05,000 --> 00:05:09,000 And when blood clots the platelets in the, in the blood, 73 00:05:09,000 --> 00:05:13,000 platelets are small cellular fragments, they have an intact 74 00:05:13,000 --> 00:05:16,000 plasma membrane but they're just, they're very tiny, they don't have a 75 00:05:16,000 --> 00:05:20,000 nucleus, and these A, A nuclear fragments, these platelets, 76 00:05:20,000 --> 00:05:24,000 when blood is induced to clot the platelets aggregate with one another 77 00:05:24,000 --> 00:05:28,000 and you form a big clump, and that, a clot settles to the 78 00:05:28,000 --> 00:05:32,000 bottom of the test-tube. But in the context of wounding, 79 00:05:32,000 --> 00:05:36,000 let's say you make a cut on your skin, what happens is that blood 80 00:05:36,000 --> 00:05:40,000 rushes into the site of, of the, the cut or the wound, 81 00:05:40,000 --> 00:05:44,000 clotting occurs in order to create coagulation. And why is there 82 00:05:44,000 --> 00:05:48,000 coagulation? In order to staunch the bleeding. In order to prevent 83 00:05:48,000 --> 00:05:52,000 there to be further hemorrhage, further loss of blood. But at the 84 00:05:52,000 --> 00:05:56,000 same time, as the platelets are aggregating to help form the 85 00:05:56,000 --> 00:06:00,000 structure of the clot that, that creates a physical barrier to 86 00:06:00,000 --> 00:06:04,000 prevent further bleeding, simultaneously the platelets are 87 00:06:04,000 --> 00:06:08,000 releasing a lot of growth factors into the medium around them. 88 00:06:08,000 --> 00:06:13,000 Why are they doing that? Because what's happening 89 00:06:13,000 --> 00:06:18,000 simultaneous with stopping the bleeding is that the platelets are, 90 00:06:18,000 --> 00:06:23,000 are releasing growth factors which are used in order to begin to 91 00:06:23,000 --> 00:06:28,000 reconstruct and heal the site of wounding. Consequently, 92 00:06:28,000 --> 00:06:33,000 what happens is that the platelets release growth factors. 93 00:06:33,000 --> 00:06:37,000 These growth factors stimulate cells right around the sides of the wound 94 00:06:37,000 --> 00:06:42,000 which are still viable and have not been destroyed to begin to 95 00:06:42,000 --> 00:06:46,000 proliferate in order to reconstruct and intact tissue. 96 00:06:46,000 --> 00:06:51,000 One of the most important of these, of these, of these factors that they 97 00:06:51,000 --> 00:06:55,000 release is platelet-derived growth factor. Remember GF is 98 00:06:55,000 --> 00:07:00,000 just growth factor. And platelet-derived growth factor, 99 00:07:00,000 --> 00:07:04,000 or as it's called in the trade PDGF, I mentioned it briefly last time, is 100 00:07:04,000 --> 00:07:09,000 a very potent mitogen. A mitogen is a growth stimulatory 101 00:07:09,000 --> 00:07:14,000 agent. It's an important mitogen for fibroblasts. 102 00:07:14,000 --> 00:07:18,000 Fibroblasts, as you recall, are the connective tissue, the 103 00:07:18,000 --> 00:07:23,000 connective tissue cells that are found throughout the body. 104 00:07:23,000 --> 00:07:28,000 And, therefore, if you were to, for example, add platelet-derived 105 00:07:28,000 --> 00:07:32,000 growth factor, PDGF to those fibroblasts that were 106 00:07:32,000 --> 00:07:37,000 sitting there in G zero, PDGF will stimulate the fibroblasts 107 00:07:37,000 --> 00:07:42,000 to begin to enter into the active cell cycle, to exit from G zero, 108 00:07:42,000 --> 00:07:47,000 to enter into G1, and therefore to complete a, a full cell cycle. 109 00:07:47,000 --> 00:07:51,000 And, by the way, recall what I said before, 110 00:07:51,000 --> 00:07:55,000 that after the cells leave the active, leave G zero and move 111 00:07:55,000 --> 00:07:59,000 throughout the active cell cycle and they have a lot of growth factors, 112 00:07:59,000 --> 00:08:03,000 they'll go all the way around the active growth cycle to mitosis. 113 00:08:03,000 --> 00:08:07,000 And when they emerge from mitosis, once again they'll ask themselves 114 00:08:07,000 --> 00:08:12,000 the question whether it's a good idea to continue to be in the active 115 00:08:12,000 --> 00:08:16,000 cell cycle or whether they should exit into G zero, 116 00:08:16,000 --> 00:08:21,000 perhaps doing so reversibly. Interestingly, if you look at the 117 00:08:21,000 --> 00:08:25,000 way that the cell cycle is organized then what you see is the following, 118 00:08:25,000 --> 00:08:30,000 if I can draw the cell cycle again. Here's G1. 119 00:08:30,000 --> 00:08:34,000 Here's S phase. And here's G2. And right at, 120 00:08:34,000 --> 00:08:38,000 at a distinct point toward the end of G1 is something called the 121 00:08:38,000 --> 00:08:42,000 restriction point, which is going to be very 122 00:08:42,000 --> 00:08:46,000 interesting shortly. And what happens is after cells 123 00:08:46,000 --> 00:08:50,000 emerge from G, from mitosis and they move 124 00:08:50,000 --> 00:08:54,000 throughout the, the most of G1 they're continually 125 00:08:54,000 --> 00:08:58,000 assessing their extracellular environment to determine whether or 126 00:08:58,000 --> 00:09:02,000 not there are enough growth factors around to justify their continuing 127 00:09:02,000 --> 00:09:07,000 the rest of the cell cycle. And ultimately they'll reach this 128 00:09:07,000 --> 00:09:11,000 restriction point, or as it's sometimes called the R 129 00:09:11,000 --> 00:09:15,000 point, and here they will make the final go versus no-go decision. 130 00:09:15,000 --> 00:09:19,000 So, if there have historically been enough growth factors from the 131 00:09:19,000 --> 00:09:23,000 beginning of G1 all the way to the R point then cells will commit 132 00:09:23,000 --> 00:09:27,000 themselves essentially irreversibly to going through the entire rest of 133 00:09:27,000 --> 00:09:31,000 the cell cycle, through M. Conversely, if cells reach up to 134 00:09:31,000 --> 00:09:35,000 this R point and they calculate that there are enough, 135 00:09:35,000 --> 00:09:39,000 there are not enough mitogenic growth factors to justify 136 00:09:39,000 --> 00:09:43,000 proliferation then they'll jump out of the active cell cycle and go back 137 00:09:43,000 --> 00:09:46,000 to G zero. What that means, in effect, is as follows. Once the 138 00:09:46,000 --> 00:09:50,000 cells have passed through the R point and they're over here and they 139 00:09:50,000 --> 00:09:54,000 are committed to complete the rest of the cell cycle then you can take 140 00:09:54,000 --> 00:09:58,000 growth factors out of their medium and they don't care because they 141 00:09:58,000 --> 00:10:02,000 only want to receive these stimulatory signals. 142 00:10:02,000 --> 00:10:06,000 They only care about in this window of time. Hereafter, 143 00:10:06,000 --> 00:10:11,000 they're committed essentially irreversibly to go through the rest 144 00:10:11,000 --> 00:10:15,000 of the cell cycle. There are, as it turns out, 145 00:10:15,000 --> 00:10:20,000 also growth inhibitory factors. So, here we've been talking about 146 00:10:20,000 --> 00:10:25,000 mitogens, the growth inhibitory factors. So, an important growth 147 00:10:25,000 --> 00:10:30,000 inhibitory factor is, for example, TGF beta. 148 00:10:30,000 --> 00:10:34,000 And TGF beta works exactly opposite to PDGF because it is a single which 149 00:10:34,000 --> 00:10:38,000 is present in extracellular space and tells the cell it should stop 150 00:10:38,000 --> 00:10:42,000 proliferating. And, therefore, 151 00:10:42,000 --> 00:10:47,000 TGF beta, if it's present in large amounts in this part of the cell 152 00:10:47,000 --> 00:10:51,000 cycle, if the cell experiences it in large amounts, 153 00:10:51,000 --> 00:10:55,000 that will influence the cell not to move through the restriction point. 154 00:10:55,000 --> 00:10:59,000 Conversely, if it's absent then obviously PDGF can have the, 155 00:10:59,000 --> 00:11:04,000 the undiluted tensions of the cell. And, therefore, 156 00:11:04,000 --> 00:11:08,000 what I'm trying to convey by this is to tell you that cell balances both 157 00:11:08,000 --> 00:11:12,000 its growth stimulatory and growth inhibitory signals that it's 158 00:11:12,000 --> 00:11:16,000 receiving from extracellular space, these decisions are weighed, and 159 00:11:16,000 --> 00:11:20,000 finally down here the cell with make the, the binary decision to go ahead 160 00:11:20,000 --> 00:11:24,000 or not to go ahead, depending on historically how many 161 00:11:24,000 --> 00:11:29,000 of these factors its recruited in this specific window of time. 162 00:11:29,000 --> 00:11:33,000 Recall, as we said last time, that once a growth factor like PDGF 163 00:11:33,000 --> 00:11:37,000 goes to the plasma membrane it encounters a receptor on the surface 164 00:11:37,000 --> 00:11:42,000 which let's say we call the PDGF receptor. And I'll just draw it 165 00:11:42,000 --> 00:11:46,000 like this for the moment. It's a transmembrane protein. 166 00:11:46,000 --> 00:11:51,000 The extracellular domain is on the outside. And I'm drawing two copies 167 00:11:51,000 --> 00:11:55,000 of the PDGF receptor here for reasons that will become 168 00:11:55,000 --> 00:12:00,000 apparent in a moment. And what happens is that PDGF which, 169 00:12:00,000 --> 00:12:04,000 for example, can be itself a dimer-, it can be a dimeric growth factor. 170 00:12:04,000 --> 00:12:09,000 So, it has two distinct subunits in it. They're both essentially 171 00:12:09,000 --> 00:12:13,000 equivalent to one another but it is dimeric. And this dimeric structure, 172 00:12:13,000 --> 00:12:18,000 PDGF, allows it to bind to two growth factor receptors 173 00:12:18,000 --> 00:12:22,000 simultaneously. Well, why is that interesting? 174 00:12:22,000 --> 00:12:27,000 It's interesting for the following reason. 175 00:12:27,000 --> 00:12:31,000 These transmembrane PDGF receptors, like the ones I've indicated right 176 00:12:31,000 --> 00:12:35,000 here, they're anchored in the plasma membrane because there's a portion 177 00:12:35,000 --> 00:12:39,000 of their sequence right in here in the transmembrane domain, 178 00:12:39,000 --> 00:12:43,000 I'm indicating it here in the orange, which contains highly hydrophobic 179 00:12:43,000 --> 00:12:47,000 amino acids. And those hydrophobic amino acids obviously love to be in 180 00:12:47,000 --> 00:12:51,000 this hydrophobic environment of the lipid bilayer and their, 181 00:12:51,000 --> 00:12:55,000 by they don't, they have no effect at all on whether the PDGF receptors 182 00:12:55,000 --> 00:13:00,000 can move, can traverse in the plane of the plasma membrane. 183 00:13:00,000 --> 00:13:03,000 So, the PDGF receptors can move across the face of the plasma 184 00:13:03,000 --> 00:13:07,000 membrane. These ones can move to the right or the left, 185 00:13:07,000 --> 00:13:10,000 but they're not going to come in or out because they're anchored in this 186 00:13:10,000 --> 00:13:14,000 lipid bilayer by this stretch of hydrophobic amino acids. 187 00:13:14,000 --> 00:13:17,000 Now, what happens interestingly when PDGF, the dimeric receptor 188 00:13:17,000 --> 00:13:21,000 binds to two of these PDGF receptor molecules, which, 189 00:13:21,000 --> 00:13:24,000 as I told you, have lateral freedom to translate laterally on the plane 190 00:13:24,000 --> 00:13:28,000 of a plasma membrane, what happens is it will bind two of 191 00:13:28,000 --> 00:13:32,000 these receptors. And, in so doing, 192 00:13:32,000 --> 00:13:36,000 it will pull the two receptor molecules next to one another. 193 00:13:36,000 --> 00:13:41,000 Previously, they were just floating around in the plane of the plasma 194 00:13:41,000 --> 00:13:46,000 membrane having bound their ligand, recall that PDGF is considered a 195 00:13:46,000 --> 00:13:50,000 ligand for the PDGF receptor, having, it will cause these two 196 00:13:50,000 --> 00:13:55,000 receptor molecules to now become, become pulled very close to one 197 00:13:55,000 --> 00:14:00,000 another. So, I'll redraw it now like this. 198 00:14:00,000 --> 00:14:03,000 Now these two receptor molecules look like this, 199 00:14:03,000 --> 00:14:07,000 they're right, they're cheek by jowl, they're right next to one another, 200 00:14:07,000 --> 00:14:11,000 and this has some interesting consequences. Of great interest 201 00:14:11,000 --> 00:14:15,000 here is the affect this has on the ability of the PDGF receptor to emit 202 00:14:15,000 --> 00:14:18,000 signals into the cytoplasm. Because recall that the end game 203 00:14:18,000 --> 00:14:22,000 here is always how does the, how does the intracellular part of 204 00:14:22,000 --> 00:14:26,000 the cell know that this, there's been an encounter with the 205 00:14:26,000 --> 00:14:30,000 growth factor in the extracellular space? 206 00:14:30,000 --> 00:14:35,000 And this signal-emitting power to PDGF receptor comes from the fact 207 00:14:35,000 --> 00:14:40,000 that once these two domains are brought together, 208 00:14:40,000 --> 00:14:45,000 each of these two domains is able to modify the other and change the 209 00:14:45,000 --> 00:14:50,000 other, i.e., subunit A modifies subunit B, subunit B modifies 210 00:14:50,000 --> 00:14:55,000 subunit A. And how is this modification achieved? 211 00:14:55,000 --> 00:15:00,000 For the follow, it is achieved in the following way. 212 00:15:00,000 --> 00:15:04,000 That the, this domain, which I've been calling, 213 00:15:04,000 --> 00:15:08,000 I've just been writing like this, as a rectangle, is actually a 214 00:15:08,000 --> 00:15:13,000 catalytic agent. It's actually a tyrosine kinase. 215 00:15:13,000 --> 00:15:17,000 So, it's an enzyme. And a tyrosine kinase is an enzyme that takes the 216 00:15:17,000 --> 00:15:22,000 gamma phosphate from ATP, the high energy phosphate from APT, 217 00:15:22,000 --> 00:15:26,000 ATP and transfers it to tyrosine amino acids that are present 218 00:15:26,000 --> 00:15:31,000 on substrates. So, if here is an amino acid 219 00:15:31,000 --> 00:15:35,000 sequence in the single letter, letter code, and if we admit that Y 220 00:15:35,000 --> 00:15:40,000 is the, is the code for tyrosine then if here's a protein that it 221 00:15:40,000 --> 00:15:44,000 functions as a substrate for a tyrosine kinase, 222 00:15:44,000 --> 00:15:48,000 a tyrosine kinase will add a phosphate group to the side chain of 223 00:15:48,000 --> 00:15:53,000 the tyrosine, which I'm not drawing here, but tyrosine has a hydroxyl 224 00:15:53,000 --> 00:15:57,000 group in its side chain and, therefore, it will phosphorilate 225 00:15:57,000 --> 00:16:02,000 this tyrosine. That is to say will tetraphosphate 226 00:16:02,000 --> 00:16:06,000 group do it? It will phosphorilate this tyrosine. 227 00:16:06,000 --> 00:16:11,000 So, these two rectangles are, in fact, tyrosine kinases. And what 228 00:16:11,000 --> 00:16:16,000 happens, after the two subunits of the receptor have been brought 229 00:16:16,000 --> 00:16:20,000 together, is thereafter, what one finds is that each of these 230 00:16:20,000 --> 00:16:25,000 receptor subunits becomes multiply phosphorilated. 231 00:16:25,000 --> 00:16:30,000 And each of these lollipops that I'm indicating here are sites where 232 00:16:30,000 --> 00:16:35,000 there, a tyrosine residue has become phosphorilated. 233 00:16:35,000 --> 00:16:38,000 In fact, there's a tail of the PDGF receptor that extends even further 234 00:16:38,000 --> 00:16:42,000 to the cytoplasm which also acquires a number of different phosphates on 235 00:16:42,000 --> 00:16:46,000 it. And, again, I'd remind us that this 236 00:16:46,000 --> 00:16:50,000 phosphorylation is really what's often called transphosphorylation 237 00:16:50,000 --> 00:16:53,000 because each receptor molecule phosphorilates the tyrosine residues 238 00:16:53,000 --> 00:16:57,000 on the other. Obviously, when these two receptor molecules 239 00:16:57,000 --> 00:17:01,000 are far apart in the plain of the plasma membrane, 240 00:17:01,000 --> 00:17:05,000 this transphosphorylation cannot occur. 241 00:17:05,000 --> 00:17:09,000 But once the two tyrosine kinase residues, once the two tyrosine 242 00:17:09,000 --> 00:17:13,000 kinases have been brought together, pulled together by the dimerization 243 00:17:13,000 --> 00:17:17,000 of the receptor, now this cross-phosphorylation, 244 00:17:17,000 --> 00:17:22,000 on each phosphorylating the other can occur, and soon the receptors 245 00:17:22,000 --> 00:17:26,000 are highly phosphorilated. All of these phosphate groups, 246 00:17:26,000 --> 00:17:30,000 to repeat myself, being attached to tyrosine residues in their 247 00:17:30,000 --> 00:17:35,000 cytoplasmic domains. And this, in turn, 248 00:17:35,000 --> 00:17:39,000 creates interesting docking sites for a variety of other cytoplasmic 249 00:17:39,000 --> 00:17:44,000 signaling proteins. And we'll talk about some today and 250 00:17:44,000 --> 00:17:49,000 next time, but what I want to leave you with is the following impression. 251 00:17:49,000 --> 00:17:53,000 That after this phosphorylation actually occurs there are a number 252 00:17:53,000 --> 00:17:58,000 of molecules in the cytoplasm, signaling molecules that have 253 00:17:58,000 --> 00:18:03,000 affinity for binding these phosphotyrosines. 254 00:18:03,000 --> 00:18:07,000 When I say phosphotyrosine, obviously, I'm referring to the 255 00:18:07,000 --> 00:18:11,000 phosphorilated form of tyrosine that's been created by a tyrosine 256 00:18:11,000 --> 00:18:15,000 kinase enzyme. So, here's one molecule that can 257 00:18:15,000 --> 00:18:19,000 bind. Here's molecule A combined to one of these phosphates, 258 00:18:19,000 --> 00:18:23,000 another one combined to this phosphate specifically, 259 00:18:23,000 --> 00:18:27,000 and each of these molecules, once they're attracted to this 260 00:18:27,000 --> 00:18:31,000 phosphorilated receptor, can then emit downstream signals, 261 00:18:31,000 --> 00:18:35,000 send a variety of signals into the cell that ultimately end up in 262 00:18:35,000 --> 00:18:40,000 persuading the cell to proliferate. 263 00:18:40,000 --> 00:18:45,000 And so these effects here of growth factors in the G1 phase of the cell 264 00:18:45,000 --> 00:18:50,000 cycle are mediated by this transmembrane signaling, 265 00:18:50,000 --> 00:18:55,000 by the activation of these, of this PDGF receptor, for example, 266 00:18:55,000 --> 00:19:00,000 and by the resulting a release of downstream signals into the cell 267 00:19:00,000 --> 00:19:05,000 which pursued the cell to proliferate or not to proliferate. 268 00:19:05,000 --> 00:19:08,000 To be sure the, when platelets clot, 269 00:19:08,000 --> 00:19:12,000 when platelets aggregate and they release PDGF, they also release 270 00:19:12,000 --> 00:19:15,000 other kinds of growth factors. For instance, there's another 271 00:19:15,000 --> 00:19:19,000 growth factor that's called IGF1, insulin-like growth factor, and that 272 00:19:19,000 --> 00:19:22,000 has its own receptor on the surface of cells. And there are, 273 00:19:22,000 --> 00:19:26,000 on a cell, hundreds to thousands of these PDGF receptors, 274 00:19:26,000 --> 00:19:30,000 there are IGF receptors, there are EGF receptors. 275 00:19:30,000 --> 00:19:34,000 And a cell often will require several distinct kinds of growth 276 00:19:34,000 --> 00:19:38,000 factor activations in order to proliferate. So, 277 00:19:38,000 --> 00:19:42,000 this is only a minor part of the entire exposure that a cell 278 00:19:42,000 --> 00:19:47,000 experiences in the G1 phase of the cell cycle. To elaborate on a point 279 00:19:47,000 --> 00:19:51,000 that I made last time, an important biological distinction 280 00:19:51,000 --> 00:19:55,000 between normal cells and cancer cells is the fact that cancer cells 281 00:19:55,000 --> 00:19:59,000 require relatively little growth factors or in the medium in order to 282 00:19:59,000 --> 00:20:04,000 proliferate. Normal cells have a very strong 283 00:20:04,000 --> 00:20:08,000 requirement for growth factors in their medium. And, 284 00:20:08,000 --> 00:20:13,000 therefore, what we can already imagine is the following kind of 285 00:20:13,000 --> 00:20:17,000 scenario. That cancer cells have someone deregulated this signaling 286 00:20:17,000 --> 00:20:21,000 pathway. Somehow they have become independent of the stimulation that 287 00:20:21,000 --> 00:20:26,000 is normally required, usually required for cells to 288 00:20:26,000 --> 00:20:30,000 proliferate. And, in fact, we know of several 289 00:20:30,000 --> 00:20:35,000 different ways by which cancer cells can acquire this independence. 290 00:20:35,000 --> 00:20:39,000 One of the most important ways, it's, it a really interesting one, 291 00:20:39,000 --> 00:20:43,000 is here's a cancer cell, which we'll talk about very shortly. 292 00:20:43,000 --> 00:20:47,000 And what you find in certain kinds of cancer cells is that the cancer 293 00:20:47,000 --> 00:20:52,000 cells themselves release growth factors into the medium. 294 00:20:52,000 --> 00:20:56,000 So, there are certain kinds of cancer cells that will release, 295 00:20:56,000 --> 00:21:00,000 let's say, a growth factor that's like EGF into the medium around it, 296 00:21:00,000 --> 00:21:05,000 around themselves. Well, you'll say that's kind of 297 00:21:05,000 --> 00:21:09,000 amusing. But so what. The important part here is that 298 00:21:09,000 --> 00:21:13,000 these same cancer cells have receptors for TG, 299 00:21:13,000 --> 00:21:17,000 for EGF on their surface. So, they're producing a growth 300 00:21:17,000 --> 00:21:21,000 factor and they can also respond to the same growth factor. 301 00:21:21,000 --> 00:21:25,000 And, therefore, this EGF, once it's released, can swim over 302 00:21:25,000 --> 00:21:29,000 here, activate the receptor and pursued the cell to start 303 00:21:29,000 --> 00:21:33,000 proliferating. This is, if you will, 304 00:21:33,000 --> 00:21:37,000 a positive feedback loop. But note here importantly that this, 305 00:21:37,000 --> 00:21:41,000 the growth of this cell is not being controlled by growth factors coming 306 00:21:41,000 --> 00:21:45,000 from cells elsewhere in the tissue or the body. Here we're not talking 307 00:21:45,000 --> 00:21:49,000 about different cells talking to one another. Here we're talking about a 308 00:21:49,000 --> 00:21:53,000 monologue where this cell is talking to itself. This is sometimes called 309 00:21:53,000 --> 00:21:57,000 autocrine signaling and refers to the fact that certain kinds of 310 00:21:57,000 --> 00:22:02,000 cancer cells are able to make growth factors to which they can respond. 311 00:22:02,000 --> 00:22:05,000 In fact, in normal tissues it's rare for a single cell type in a normal 312 00:22:05,000 --> 00:22:09,000 tissue to be able to make a growth factor and to be able to respond to 313 00:22:09,000 --> 00:22:13,000 the same growth factor. Why can it normally not respond to 314 00:22:13,000 --> 00:22:17,000 that growth factor? Because it won't make the receptor 315 00:22:17,000 --> 00:22:21,000 for the growth factor. For example, epithelial cells like 316 00:22:21,000 --> 00:22:25,000 the cells in your skin or the cells lining the gut, 317 00:22:25,000 --> 00:22:29,000 they can release PDGF, but they don't have a PDGF receptor 318 00:22:29,000 --> 00:22:32,000 on their surface. And, therefore, 319 00:22:32,000 --> 00:22:36,000 even though they release copious amounts of PDGF, 320 00:22:36,000 --> 00:22:40,000 that will not result in this auto stimulatory proliferation and, 321 00:22:40,000 --> 00:22:44,000 therefore, you don't have this decontrolled self-proliferation that 322 00:22:44,000 --> 00:22:48,000 you see often in cancer cells, this autocrine loop. In many kinds 323 00:22:48,000 --> 00:22:52,000 of cancer cells you have another alteration of this growth factor 324 00:22:52,000 --> 00:22:56,000 signaling pathway. And here what we see is the 325 00:22:56,000 --> 00:23:00,000 following. Instead of there being a small number of growth factor 326 00:23:00,000 --> 00:23:04,000 receptors on the cell surface, now there are ten or twenty or fifty 327 00:23:04,000 --> 00:23:08,000 times more than are normally present on the cell surface. 328 00:23:08,000 --> 00:23:11,000 In other words, this growth, the growth factor 329 00:23:11,000 --> 00:23:14,000 receptors are what is called overexpressed. 330 00:23:14,000 --> 00:23:23,000 And, therefore, 331 00:23:23,000 --> 00:23:27,000 a delicate balance is disrupted because normally, 332 00:23:27,000 --> 00:23:31,000 let's say, a cell with have on its surface 500 EGF receptors, 333 00:23:31,000 --> 00:23:35,000 but in many kinds of cancers probably 30% or 40% of all 334 00:23:35,000 --> 00:23:39,000 carcinomas, carcinomas are the tumors from epithelial tissues, 335 00:23:39,000 --> 00:23:42,000 you'll find overexpressed EGF receptor. Well, 336 00:23:42,000 --> 00:23:46,000 why is that interesting? It's interesting for the following 337 00:23:46,000 --> 00:23:50,000 reason. I told you before that the activation of a receptor depends on 338 00:23:50,000 --> 00:23:54,000 its ligand to persuading two receptor subunits to come together 339 00:23:54,000 --> 00:23:58,000 and start firing, as we just discussed. 340 00:23:58,000 --> 00:24:01,000 But if now all of a sudden the cell contains large amounts of this 341 00:24:01,000 --> 00:24:04,000 growth being expressed, of the growth factor receptor being 342 00:24:04,000 --> 00:24:07,000 expressed on the surface, ten or a hundred times more than 343 00:24:07,000 --> 00:24:11,000 normal, then these growth factor receptors are going to be rather 344 00:24:11,000 --> 00:24:14,000 densely packed on the cell surface. And now they may just come together 345 00:24:14,000 --> 00:24:17,000 because they happen to bump into each other very frequently. 346 00:24:17,000 --> 00:24:21,000 They don't need the growth factor to pull them together just because 347 00:24:21,000 --> 00:24:24,000 there are so many of them. So, there's random interactions, 348 00:24:24,000 --> 00:24:27,000 random bumping together And these two growth factor 349 00:24:27,000 --> 00:24:31,000 receptors may just bump together and thereby send signals into the cell 350 00:24:31,000 --> 00:24:35,000 persuading the cell that there's been some kind of growth factor in 351 00:24:35,000 --> 00:24:39,000 the extracellular domain that's been encountered when, 352 00:24:39,000 --> 00:24:42,000 in fact, all that's happened is that there are so many of these growth 353 00:24:42,000 --> 00:24:46,000 factor receptors around that they're constantly bumping into each other, 354 00:24:46,000 --> 00:24:50,000 and while they've collided with one another they can activate signaling 355 00:24:50,000 --> 00:24:54,000 and release growth stimulatory signals into the cell. 356 00:24:54,000 --> 00:24:58,000 There's another kind of, of alteration of growth factor 357 00:24:58,000 --> 00:25:03,000 receptors that's also seen in many kinds of human tumors. 358 00:25:03,000 --> 00:25:08,000 For example, in, in glioblastomas, which is a brain tumor. And a 359 00:25:08,000 --> 00:25:13,000 glioblastoma has the following kind of, of receptor on the surface. 360 00:25:13,000 --> 00:25:18,000 It has truncated forms of the EGF receptor on the surface where a lot 361 00:25:18,000 --> 00:25:22,000 of the ectodomain is simply not present. So, here's the normal EGF 362 00:25:22,000 --> 00:25:27,000 receptor, here is a truncated EGF receptor where a lot of the 363 00:25:27,000 --> 00:25:32,000 extracellular domain, which I'm calling the ectodomain, 364 00:25:32,000 --> 00:25:37,000 has simply been lopped off. How has it be lopped off? 365 00:25:37,000 --> 00:25:41,000 Well, there's been a mutation it the gene which has, 366 00:25:41,000 --> 00:25:45,000 in effect, deleted segments in coding the N-terminus of the 367 00:25:45,000 --> 00:25:49,000 receptor protein, which normally sticks its head out 368 00:25:49,000 --> 00:25:54,000 of the cell. And now you have these truncated receptors. 369 00:25:54,000 --> 00:25:58,000 And such truncated EGF receptors are able to fire constitutively. 370 00:25:58,000 --> 00:26:02,000 Constitutively implies that these receptors are able to fire in a 371 00:26:02,000 --> 00:26:07,000 fashion that is no longer regulated by physiologic signals. 372 00:26:07,000 --> 00:26:10,000 It's a high steady rate. So now these receptor molecules, 373 00:26:10,000 --> 00:26:14,000 these truncated receptor molecules flood the cell with growth 374 00:26:14,000 --> 00:26:18,000 stimulatory signal and, for reasons that aren't really clear 375 00:26:18,000 --> 00:26:22,000 to this day, these two, these receptor, truncated receptor 376 00:26:22,000 --> 00:26:26,000 molecules can dimerize, they can come together even if 377 00:26:26,000 --> 00:26:30,000 there's no extracellular ligand present, even if there's no growth 378 00:26:30,000 --> 00:26:34,000 factor in the extracellular space. And we now realize, 379 00:26:34,000 --> 00:26:38,000 for example, that there are a variety of structurally altered 380 00:26:38,000 --> 00:26:42,000 receptors that fire constitutively into a cell in many kinds of human 381 00:26:42,000 --> 00:26:46,000 tumors. And in each case the cancer cell is deluded into thinking that 382 00:26:46,000 --> 00:26:50,000 some growth factor has been encountered out here when, 383 00:26:50,000 --> 00:26:54,000 in fact, there's not at all. Once again, what we see is a 384 00:26:54,000 --> 00:26:58,000 situation in which the cell, the cancer cell is being deluded 385 00:26:58,000 --> 00:27:03,000 into thinking there's growth factors present, extracellular space. 386 00:27:03,000 --> 00:27:07,000 None has been present at all. There have been a variety of drugs 387 00:27:07,000 --> 00:27:12,000 developed against, for example, lung cancer. 388 00:27:12,000 --> 00:27:17,000 And there are a variety of different kinds of lung cancers. 389 00:27:17,000 --> 00:27:22,000 One is called non-small cell lung carcinoma. We don't have to deal 390 00:27:22,000 --> 00:27:26,000 with the subsets of lung cancers. And it turned out, it turned out 391 00:27:26,000 --> 00:27:31,000 that one of these drugs, it's called Iressa, had very mixed 392 00:27:31,000 --> 00:27:38,000 effects on patients. 393 00:27:38,000 --> 00:27:42,000 In about 90% of these, of the class of lung cancers, 394 00:27:42,000 --> 00:27:47,000 patients that were treated, the drug Iressa, used over the last several 395 00:27:47,000 --> 00:27:51,000 years, had almost no effect on the tumor treatment and the patients 396 00:27:51,000 --> 00:27:56,000 continued to, to proceed to their death. It had, 397 00:27:56,000 --> 00:28:00,000 it really had no effect. But in 10%, in fact, there was some 398 00:28:00,000 --> 00:28:05,000 dramatic responses and tumors shrunk down. 399 00:28:05,000 --> 00:28:09,000 Now, normally a 10% response rate would be enough to cause a drug 400 00:28:09,000 --> 00:28:13,000 company to abandon all further development of the drug because it's 401 00:28:13,000 --> 00:28:17,000 just too low a response and who wants to take a drug where the 402 00:28:17,000 --> 00:28:21,000 chances of having a good response are as low as 10%? 403 00:28:21,000 --> 00:28:25,000 It's just not a good situation. But then some geneticists here in 404 00:28:25,000 --> 00:28:29,000 Boston, one group at the MGH and another over at the Dana Farber, 405 00:28:29,000 --> 00:28:33,000 began to look at the lung cancer cells that responded, 406 00:28:33,000 --> 00:28:37,000 i.e., from tumors of patients that responded and shrank in response to 407 00:28:37,000 --> 00:28:41,000 the drug and the lung, and the lung cancer cells of 408 00:28:41,000 --> 00:28:44,000 patients who didn't. It turns out that Iressa is an 409 00:28:44,000 --> 00:28:48,000 inhibitor of the tyrosine kinase of the EGF receptor. 410 00:28:48,000 --> 00:28:52,000 That's how it was designed. In other words, this drug, it's a 411 00:28:52,000 --> 00:28:56,000 low molecular weight drug and it goes into the tyrosine kinase domain, 412 00:28:56,000 --> 00:29:00,000 that rectangular thing I showed you before very schematically, 413 00:29:00,000 --> 00:29:04,000 and it shuts down the firing of the receptor. 414 00:29:04,000 --> 00:29:08,000 That was the motivation behind creating this drug. 415 00:29:08,000 --> 00:29:13,000 So, Iressa shuts down the EGF receptor and 10% of lung cancer 416 00:29:13,000 --> 00:29:18,000 patients, their tumor shrank, the other 90% didn't, weren't 417 00:29:18,000 --> 00:29:22,000 effected at all. And what these two groups of 418 00:29:22,000 --> 00:29:27,000 geneticists found over the last three or four months is that the 419 00:29:27,000 --> 00:29:32,000 patients whose tumors responded had tumor cells where the EGF receptor 420 00:29:32,000 --> 00:29:37,000 was mutated and therefore firing in a constitutively active fashion. 421 00:29:37,000 --> 00:29:40,000 That is to say there were actually structural alterations in the 422 00:29:40,000 --> 00:29:44,000 receptor. This is a massive structural alteration of the 423 00:29:44,000 --> 00:29:48,000 receptor here, this truncation. 424 00:29:48,000 --> 00:29:52,000 But, in fact, in certain patients the 10% of patients that responded, 425 00:29:52,000 --> 00:29:56,000 there were much more subtle changes in the cytoplasmic domain of the 426 00:29:56,000 --> 00:30:00,000 protein which allowed these receptors to constitutively dimerize, 427 00:30:00,000 --> 00:30:04,000 once again, in a ligand independent fashion. 428 00:30:04,000 --> 00:30:08,000 So, these subtle mutations mimic, in effect, the consequences of 429 00:30:08,000 --> 00:30:12,000 deleting or truncating the extracellular domain in that in both 430 00:30:12,000 --> 00:30:16,000 cases one gets a ligand independent receptor. In those cases where 431 00:30:16,000 --> 00:30:20,000 these, where the patients had a mutant EGF receptor, 432 00:30:20,000 --> 00:30:24,000 structurally altered EGF receptor that was firing constitutively, 433 00:30:24,000 --> 00:30:28,000 there were dramatic responses to the Iressa drug. 434 00:30:28,000 --> 00:30:31,000 In the 90% of patients where there was no effective response to the 435 00:30:31,000 --> 00:30:35,000 drug, the EGF receptor was wild-type, it was present in a wild-type 436 00:30:35,000 --> 00:30:39,000 configuration. It might have been slightly 437 00:30:39,000 --> 00:30:43,000 overexpressed but it wasn't, but it continued to, to function 438 00:30:43,000 --> 00:30:46,000 essentially as a normal EGF receptor. And this represents a major advance 439 00:30:46,000 --> 00:30:50,000 in cancer therapy because it suggests that one has to begin to 440 00:30:50,000 --> 00:30:54,000 understand what subsets of patients one should treat with a drug which 441 00:30:54,000 --> 00:30:58,000 can, on its own, have quite toxic effects on the 442 00:30:58,000 --> 00:31:01,000 patient. And, from now on, 443 00:31:01,000 --> 00:31:05,000 to state the obvious, when one gets lung cancer patients 444 00:31:05,000 --> 00:31:09,000 one will check quickly using various reactions, like the PCR reaction, 445 00:31:09,000 --> 00:31:13,000 to see whether or not their cancer cells have a mutated EGF receptor. 446 00:31:13,000 --> 00:31:16,000 And, if they do, they will be candidates for Iressa treatment with 447 00:31:16,000 --> 00:31:20,000 the expectation that 60%, 80% or even 100% of them will have 448 00:31:20,000 --> 00:31:24,000 tumors that respond. And if they don't have a mutated 449 00:31:24,000 --> 00:31:28,000 EGF receptor then they will not be subjected to a treatment 450 00:31:28,000 --> 00:31:31,000 by this drug. This is the beginning of a new era 451 00:31:31,000 --> 00:31:35,000 of cancer drug treatment. It's called rational drug design, 452 00:31:35,000 --> 00:31:39,000 or rational treatment, where you don't just lump all the patients 453 00:31:39,000 --> 00:31:43,000 with a certain disease together and say let's give them all this drug 454 00:31:43,000 --> 00:31:46,000 and throw things up in the air and see what happens. 455 00:31:46,000 --> 00:31:50,000 Here one begins to do a genetic diagnosis of the genomes of the 456 00:31:50,000 --> 00:31:54,000 patient's cancer cells in order to determine whether or not they have 457 00:31:54,000 --> 00:31:58,000 certain mutated genes. In this case we're referring to one 458 00:31:58,000 --> 00:32:02,000 of these growth factor receptors. By the way, we're talking about lung 459 00:32:02,000 --> 00:32:06,000 cancer today, right? If you are smoking now, 460 00:32:06,000 --> 00:32:10,000 I always ask the class how many people are smoking, 461 00:32:10,000 --> 00:32:14,000 and nobody has the, has the moral fortitude to raise their hands. 462 00:32:14,000 --> 00:32:18,000 But if you are smoking now and you started at this age and you continue. 463 00:32:18,000 --> 00:32:22,000 And, by the way, if you start at your age and you 464 00:32:22,000 --> 00:32:26,000 continue smoke, stopping smoking is actually a bit 465 00:32:26,000 --> 00:32:30,000 more difficult, quite a bit more difficult than 466 00:32:30,000 --> 00:32:34,000 stopping heroine. That's pretty interesting, 467 00:32:34,000 --> 00:32:38,000 right? So, if you continue to smoke now you will be healthy for a pretty 468 00:32:38,000 --> 00:32:42,000 long period of time, probably another 20 or 30 years. 469 00:32:42,000 --> 00:32:46,000 And for you that sounds like forever, but when you get to be 470 00:32:46,000 --> 00:32:50,000 about 40 or 50 things are going to start falling apart. 471 00:32:50,000 --> 00:32:54,000 Soon you won't be able to be very athletic, soon your lungs are going 472 00:32:54,000 --> 00:32:58,000 to be able, are going to degrade, and by the time you reach your 473 00:32:58,000 --> 00:33:02,000 fifties, sixties or seventies what's going to happen is you will, 474 00:33:02,000 --> 00:33:06,000 on average, have a six to eight year shortened life expectancy. 475 00:33:06,000 --> 00:33:09,000 Now you say six to eight years is not that much, 476 00:33:09,000 --> 00:33:13,000 but it really is. You know, when you get to be 70 and 477 00:33:13,000 --> 00:33:17,000 you think you're going to die next year or you're going to die in six 478 00:33:17,000 --> 00:33:20,000 or eight years it makes a big difference. Six to eight years is 479 00:33:20,000 --> 00:33:24,000 an enormous difference in life expectancy. 20% of all people who 480 00:33:24,000 --> 00:33:28,000 died last year in this country, 20% of all deaths came from 481 00:33:28,000 --> 00:33:32,000 cigarette smoking. Imagine that. And when you die from cigarette 482 00:33:32,000 --> 00:33:36,000 smokes, smoking sometimes you get lung cancer. There probably were, 483 00:33:36,000 --> 00:33:40,000 I think, 600,000 people who died from smoking last year. 484 00:33:40,000 --> 00:33:44,000 Six hundred thousand. There were 55,000 American soldiers who died in 485 00:33:44,000 --> 00:33:48,000 Vietnam in the whole war, there were 220,000 American soldiers 486 00:33:48,000 --> 00:33:52,000 who died in all of World War II, and last year in this, and there 487 00:33:52,000 --> 00:33:56,000 were 3,000, or 2, 00 people who died in the World 488 00:33:56,000 --> 00:34:00,000 Trade Center. All right? Got all those numbers? 489 00:34:00,000 --> 00:34:05,000 So, last year 600, 00 people died premature deaths 490 00:34:05,000 --> 00:34:10,000 because they were smoking. How many people died last year from 491 00:34:10,000 --> 00:34:15,000 smoking marijuana? Maybe two or three, 492 00:34:15,000 --> 00:34:20,000 I don't know. [APPLAUSE] Am I urging you to do any kind of smoking? 493 00:34:20,000 --> 00:34:25,000 I'm not saying marijuana smoking is good for you, but I just want you to 494 00:34:25,000 --> 00:34:30,000 get these things in mind, the perspective. 495 00:34:30,000 --> 00:34:33,000 If you smoke, you know, in many countries, including this 496 00:34:33,000 --> 00:34:37,000 one, there isn't much tension by, given by the government to, 497 00:34:37,000 --> 00:34:40,000 dissuading people from smoking, and here's the reason why. If you 498 00:34:40,000 --> 00:34:44,000 smoke, and you going to get, get sick eventually, eventually the 499 00:34:44,000 --> 00:34:47,000 country is always going to have to pay for your medical costs, 500 00:34:47,000 --> 00:34:51,000 right? Sooner or later we all have to pay for the costs of people who 501 00:34:51,000 --> 00:34:54,000 get sick. It's all shared in one way or another. 502 00:34:54,000 --> 00:34:58,000 But it's not such a big problem for a government like the 503 00:34:58,000 --> 00:35:02,000 American government. Because if you smoke you're going to 504 00:35:02,000 --> 00:35:06,000 die early enough that you won't draw on social security. 505 00:35:06,000 --> 00:35:10,000 And, therefore, the government actually saves money by your smoking, 506 00:35:10,000 --> 00:35:14,000 because by the time they add up how much they get on the tobacco tax and 507 00:35:14,000 --> 00:35:18,000 how much they earn by your not living long enough to draw a pension, 508 00:35:18,000 --> 00:35:22,000 it's much better, it's much more money than how much 509 00:35:22,000 --> 00:35:26,000 it's going to cost to take care of you while you're dying from 510 00:35:26,000 --> 00:35:30,000 emphysema or bladder cancer or lung cancer or heart disease. 511 00:35:30,000 --> 00:35:33,000 Many more people die from heart attacks due to smoking than die from 512 00:35:33,000 --> 00:35:37,000 lung cancer, in fact. So, think about this. 513 00:35:37,000 --> 00:35:41,000 Think about this. If you smoke it's probably a good time to stop 514 00:35:41,000 --> 00:35:45,000 because if you continue at your age, especially if you're women, which is 515 00:35:45,000 --> 00:35:48,000 women, for some reason women have a harder time stopping than men, 516 00:35:48,000 --> 00:35:52,000 they can't say why. It's probably some physiological thing. 517 00:35:52,000 --> 00:35:56,000 If you, if you continue now at your age, it will be almost impossible to 518 00:35:56,000 --> 00:36:00,000 stop. If you live with smokers ask them to leave. [LAUGHTER] 519 00:36:00,000 --> 00:36:04,000 If you live at home with your parents and they smoke tell them 520 00:36:04,000 --> 00:36:08,000 it's time for them to leave. Throw them out of the house. 521 00:36:08,000 --> 00:36:12,000 Smoke, second-hand smoking killed probably between 60, 522 00:36:12,000 --> 00:36:16,000 00 and 80,000 people last year in this country. Second-hand smoke. 523 00:36:16,000 --> 00:36:20,000 And, by the way, if you want to see an interesting phenomenon, 524 00:36:20,000 --> 00:36:24,000 go to a veterinary hospital because there they with great frequently, 525 00:36:24,000 --> 00:36:28,000 frequency treat dogs who have lung cancer. And why do they 526 00:36:28,000 --> 00:36:32,000 have lung cancer? Not in 99% of the cases, 527 00:36:32,000 --> 00:36:36,000 in 100% of the cases these dogs live with owners who smoke. 528 00:36:36,000 --> 00:36:40,000 An average tobacco smoker goes through six or eight dogs in his or 529 00:36:40,000 --> 00:36:44,000 her lifetime. [LAUGHTER] It's true. It's absolutely true. 530 00:36:44,000 --> 00:36:49,000 So if you, if you think the dogs, if that's a fact for the, for the, 531 00:36:49,000 --> 00:36:53,000 for the dog owners, think about what's happening to the 532 00:36:53,000 --> 00:36:57,000 inside of your lungs. And so I'm going to take back what 533 00:36:57,000 --> 00:37:02,000 I said before. Before I told you that the most 534 00:37:02,000 --> 00:37:06,000 important thing for you to do in this course is to learn how to think 535 00:37:06,000 --> 00:37:10,000 clearly and to assess and to distil conceptually complex material, 536 00:37:10,000 --> 00:37:14,000 there's actually one more thing that's even more important to get 537 00:37:14,000 --> 00:37:18,000 out of this course, if you do, and that is to stop 538 00:37:18,000 --> 00:37:22,000 smoking. If you do that, if you do that it'll be vastly more 539 00:37:22,000 --> 00:37:26,000 important for the rest of your life than anything you learn here. 540 00:37:26,000 --> 00:37:30,000 So, write that down, vastly more important. You may think it's 541 00:37:30,000 --> 00:37:34,000 glamorous, you may think it's exciting, but keep in mind, 542 00:37:34,000 --> 00:37:38,000 people who stop smoking have vastly greater effects on reducing the 543 00:37:38,000 --> 00:37:42,000 morbidity and the mortality in this country than anything that cancer 544 00:37:42,000 --> 00:37:46,000 researchers can do. Keep that in mind. 545 00:37:46,000 --> 00:37:50,000 And if you start smoking now and you think that somehow the cancer 546 00:37:50,000 --> 00:37:53,000 researchers are going to be able to come up with some miracle cure by 547 00:37:53,000 --> 00:37:56,000 this time you start coughing and start spitting up blood, 548 00:37:56,000 --> 00:38:00,000 don't be so certain. They may not be able to save you, 549 00:38:00,000 --> 00:38:04,000 to pull your fat out of the fire. So, I don't know whether I, 550 00:38:04,000 --> 00:38:08,000 I gave this message in a very subtle way or I hit you over the head with 551 00:38:08,000 --> 00:38:12,000 it. [LAUGHTER] But think, think about that. Now, now we're 552 00:38:12,000 --> 00:38:16,000 going to focus on lung cancer, we're going to focus on cancer 553 00:38:16,000 --> 00:38:20,000 because it's one of the consequences of cigarette smoking, 554 00:38:20,000 --> 00:38:24,000 but it's a disease we want to talk about both this time and next time, 555 00:38:24,000 --> 00:38:28,000 and we want to relate it here to the cell cycle and, 556 00:38:28,000 --> 00:38:32,000 and how the growth of cell proliferation occurs. 557 00:38:32,000 --> 00:38:36,000 I told you last time that a human tumor is roughly-speaking about, 558 00:38:36,000 --> 00:38:40,000 a human body roughly carries three times ten to the thirteenth cells. 559 00:38:40,000 --> 00:38:44,000 So, that's quite a few cells. That's how many cells there are in 560 00:38:44,000 --> 00:38:48,000 the human body, plus or minus. A human tumor of one, 561 00:38:48,000 --> 00:38:52,000 let's say one cubic centimeter is roughly ten to the ninth cells. 562 00:38:52,000 --> 00:38:56,000 So, a tiny tumor this way already has a billion cells in it. 563 00:38:56,000 --> 00:39:00,000 And what I want to say is that those billion cells, 564 00:39:00,000 --> 00:39:04,000 or if the tumor grows larger to ten to a hundred billion cells, 565 00:39:04,000 --> 00:39:09,000 it's still not that much compared with the overall size of the body. 566 00:39:09,000 --> 00:39:14,000 But tumors of that size can kill you. And one, an interesting and 567 00:39:14,000 --> 00:39:19,000 important thing to realize about all the cancer cells in that tumor mass 568 00:39:19,000 --> 00:39:24,000 is that they all descend from a single progenitor. 569 00:39:24,000 --> 00:39:29,000 In other words, if we imagine a situation where here are a whole 570 00:39:29,000 --> 00:39:34,000 bunch of normal cells and here's the boundary between normalcy up here 571 00:39:34,000 --> 00:39:40,000 and malignancy, malignancy obviously refers to 572 00:39:40,000 --> 00:39:45,000 cancer, we could imagine where there are many cells which independently 573 00:39:45,000 --> 00:39:50,000 cross the boundary from one to the other and become the progenitors of 574 00:39:50,000 --> 00:39:55,000 a vast tumor mass. But that's not what happens. 575 00:39:55,000 --> 00:40:00,000 What happens, in fact, is that only one cell gets converted or becomes, 576 00:40:00,000 --> 00:40:05,000 as one says here, it becomes transformed from a normal cell into 577 00:40:05,000 --> 00:40:10,000 a cancer cell. And this transformation causes this 578 00:40:10,000 --> 00:40:15,000 one cell to become the progenitor, the ancestor of all the cells in the 579 00:40:15,000 --> 00:40:20,000 tumor mass. So, one important realization we have 580 00:40:20,000 --> 00:40:25,000 about looking at different tumors is that cancers are monoclonal growths, 581 00:40:25,000 --> 00:40:30,000 i.e., they form clonal populations. They're monoclonal in the sense that 582 00:40:30,000 --> 00:40:35,000 they all are genetically derived from a single common ancestor rather 583 00:40:35,000 --> 00:40:40,000 than being polyclonal. What else can we say about cancer 584 00:40:40,000 --> 00:40:44,000 cells or the cells in a tumor? If you take cells out of Petri dish, 585 00:40:44,000 --> 00:40:48,000 out of an animal or a human and put them on a Petri dish, 586 00:40:48,000 --> 00:40:52,000 excuse me, and you put them there, then what you'll see is following 587 00:40:52,000 --> 00:40:56,000 interesting behavior. If you put normal cells in a Petri 588 00:40:56,000 --> 00:41:00,000 dish they'll grow across the bottom of the Petri dish until they cover 589 00:41:00,000 --> 00:41:04,000 the entire bottom of the Petri dish. 590 00:41:04,000 --> 00:41:08,000 So, you can put a hundred cells in and they'll continue to proliferate. 591 00:41:08,000 --> 00:41:12,000 Let's look at the Petri dish from top down, so you might have a small 592 00:41:12,000 --> 00:41:16,000 number of cells here and here, and normal cells will continue to 593 00:41:16,000 --> 00:41:21,000 proliferate until they begin to touch one another, 594 00:41:21,000 --> 00:41:25,000 and then they'll stop growing. And this stopping of growing is, 595 00:41:25,000 --> 00:41:30,000 is the phenomenon that's called contact inhibition. 596 00:41:30,000 --> 00:41:33,000 So, a normal cell will indicate contact inhibition. 597 00:41:33,000 --> 00:41:37,000 And to state, to state the obvious, this phenomenon or this behavior of 598 00:41:37,000 --> 00:41:40,000 contact inhibition creates what's called a cell monolayer because if 599 00:41:40,000 --> 00:41:44,000 the cell stopped growing once they touch each other they're not going 600 00:41:44,000 --> 00:41:47,000 to be two or three or four layers of cells in the Petri dish. 601 00:41:47,000 --> 00:41:51,000 So, here we're looking at this Petri dish in cross-section and 602 00:41:51,000 --> 00:41:55,000 there's a monolayer of normal cells here. 603 00:41:55,000 --> 00:41:58,000 If you put a cancer cell in the Petri dish, or let's put here a 604 00:41:58,000 --> 00:42:02,000 cancer cell, we'll seed it amidst normal cells, what will happen is 605 00:42:02,000 --> 00:42:06,000 that the cancer cell lacks, has lost contact inhibition, 606 00:42:06,000 --> 00:42:09,000 and the cancer cell will continue to proliferate even after it's touched 607 00:42:09,000 --> 00:42:13,000 its neighbors. So, it has lost cancer, 608 00:42:13,000 --> 00:42:17,000 it has lost contact inhibition and will start growing on top of, 609 00:42:17,000 --> 00:42:20,000 the cancer cells will start growing on top of each other because they 610 00:42:20,000 --> 00:42:24,000 don't mind growing in spite of their having intimate contact with 611 00:42:24,000 --> 00:42:28,000 neighboring cells. And, in fact, what you can do is 612 00:42:28,000 --> 00:42:32,000 the following experiment. You can put cells in a Petri dish 613 00:42:32,000 --> 00:42:37,000 like this, a whole bunch of normal cells in a Petri dish, 614 00:42:37,000 --> 00:42:42,000 and then you can put into them some kind of transforming influence, 615 00:42:42,000 --> 00:42:47,000 which we'll talk about very shortly, i.e., you can influence some of 616 00:42:47,000 --> 00:42:52,000 these cells to become transformed. And how we do so we'll tell, we'll 617 00:42:52,000 --> 00:42:57,000 hold in abeyance just for a moment. So, we'll have this cell. We'll do 618 00:42:57,000 --> 00:43:02,000 this cell to become transformed and this cell to become transformed. 619 00:43:02,000 --> 00:43:05,000 And what will happen is that those cells will begin to form a very 620 00:43:05,000 --> 00:43:09,000 thick clump of cells, these blue ones, the ones that are 621 00:43:09,000 --> 00:43:13,000 transformed. Whereas, all the other cells will grow until 622 00:43:13,000 --> 00:43:16,000 they form a monolayer at which point they'll stop proliferating. 623 00:43:16,000 --> 00:43:20,000 So, the cancer cells keep piling up and the transformed cells, 624 00:43:20,000 --> 00:43:24,000 transformed by one or another agent, we won't talk about that yet, 625 00:43:24,000 --> 00:43:28,000 continue to proliferate long after the normal cells have stopped 626 00:43:28,000 --> 00:43:31,000 proliferating. The normal cells having stopped 627 00:43:31,000 --> 00:43:35,000 proliferating because they're contact inhibited. 628 00:43:35,000 --> 00:43:38,000 And, therefore, they'll form this clump of cells which we'll call a 629 00:43:38,000 --> 00:43:42,000 focus. And if you hold the Petri dish up to the light and you look at 630 00:43:42,000 --> 00:43:45,000 it and there are some transformed cells present, 631 00:43:45,000 --> 00:43:49,000 you can see the foci, they're very thick. Whereas, 632 00:43:49,000 --> 00:43:52,000 the thin monolayer of cells will just look pretty transparent. 633 00:43:52,000 --> 00:43:56,000 But this focus will look highly opaque by virtue of the multiple 634 00:43:56,000 --> 00:44:00,000 layers of cells that are involved in it. 635 00:44:00,000 --> 00:44:05,000 Now, in fact, we can begin to ask the question of how and why cells 636 00:44:05,000 --> 00:44:10,000 like this become transformed and exhibit this behavior. 637 00:44:10,000 --> 00:44:16,000 In fact, until the 1980s there wasn't really a clear understanding 638 00:44:16,000 --> 00:44:21,000 about how that happened. I've already given you some clues 639 00:44:21,000 --> 00:44:27,000 because I've already told you the fact that certain cancer cells carry 640 00:44:27,000 --> 00:44:32,000 mutant genes. What kind of mutant genes? 641 00:44:32,000 --> 00:44:36,000 Well, I gave you, in anticipation of discussion, 642 00:44:36,000 --> 00:44:40,000 the fact that certain cancer cells carry mutant genes that specify 643 00:44:40,000 --> 00:44:44,000 mutant growth factor receptors. And these mutant growth factor 644 00:44:44,000 --> 00:44:49,000 receptors, as I indicated, begin to push the cell the 645 00:44:49,000 --> 00:44:53,000 proliferate. And so that already anticipates a conclusion we're about 646 00:44:53,000 --> 00:44:57,000 to make, which is that the reason why cancer cells behave abnormally 647 00:44:57,000 --> 00:45:02,000 is that they carry mutant genes. Now, let's talk about the nature of 648 00:45:02,000 --> 00:45:07,000 these mutant genes because, if you look at these mutant genes, 649 00:45:07,000 --> 00:45:12,000 invariably they are the consequences of what we call somatic mutations. 650 00:45:12,000 --> 00:45:17,000 By that I mean, I mean the following. Let's say we all start 651 00:45:17,000 --> 00:45:22,000 out with a really good set of genes. And, thank the good Lord, we all do. 652 00:45:22,000 --> 00:45:27,000 But as we go through life through accidents or through intent we can 653 00:45:27,000 --> 00:45:32,000 damage these genes. We can muck them up in different 654 00:45:32,000 --> 00:45:36,000 ways. And these genes, this damage may occur to cells in 655 00:45:36,000 --> 00:45:41,000 the skin, they may occur to cells in your belly, they may occur to cells 656 00:45:41,000 --> 00:45:45,000 in the brain, and these are called somatic mutations in contrast to the 657 00:45:45,000 --> 00:45:50,000 germline mutations that affect one's offspring. Because, 658 00:45:50,000 --> 00:45:54,000 as you must realize by now, the only way you can have mutations 659 00:45:54,000 --> 00:45:59,000 that affect your descendents is if those mutations strike in the gonads 660 00:45:59,000 --> 00:46:04,000 and affect the genomes of either sperm or egg. 661 00:46:04,000 --> 00:46:08,000 But the mutations occurring everywhere else in the body outside 662 00:46:08,000 --> 00:46:12,000 of the gonads, because they occur in, 663 00:46:12,000 --> 00:46:16,000 I think I, this is somatic, excuse me, because they occur in the 664 00:46:16,000 --> 00:46:21,000 soma, the soma is defined as the entirety of the body outside of the 665 00:46:21,000 --> 00:46:25,000 gonads, outside of the germi, these somatic mutations might affect 666 00:46:25,000 --> 00:46:29,000 the tissues around them but they will not be transmitted from one 667 00:46:29,000 --> 00:46:34,000 organismic generation to the next. And, accordingly, 668 00:46:34,000 --> 00:46:38,000 we begin to imagine, in fact, correctly we begin to 669 00:46:38,000 --> 00:46:42,000 construct this model that one of the most important mechanisms of 670 00:46:42,000 --> 00:46:46,000 creating a cancer cell is to damage its genome. So, 671 00:46:46,000 --> 00:46:50,000 I'll tell you a story now, which I'm only going to finish on 672 00:46:50,000 --> 00:46:54,000 Monday. We have, let's imagine, a 55-year-old, 673 00:46:54,000 --> 00:46:58,000 this is a true story, 55-year-old man who's been smoking since he or 674 00:46:58,000 --> 00:47:02,000 she, he was 15 years old. So, he's been smoking for 40 years. 675 00:47:02,000 --> 00:47:06,000 And during those periods of 40 years, by the way, I'm not saying whether 676 00:47:06,000 --> 00:47:10,000 I'm for or against smoking, you understand that. During that 677 00:47:10,000 --> 00:47:15,000 period of 40 years this person has been introducing large amounts of 678 00:47:15,000 --> 00:47:19,000 tobacco smoke compounds into his lungs. Now, it turns out that these 679 00:47:19,000 --> 00:47:23,000 compounds, this tobacco smoke compounds are carcinogens. 680 00:47:23,000 --> 00:47:28,000 You know carcinogen means it causes cancer. But it happens also to be 681 00:47:28,000 --> 00:47:32,000 the case that a lot of carcinogens, cancer-causing compounds are also 682 00:47:32,000 --> 00:47:37,000 mutagens. That is to say they can mutate DNA. 683 00:47:37,000 --> 00:47:41,000 So, here we have a scenario that we're going to set up for next time. 684 00:47:41,000 --> 00:47:46,000 55-year-old man. Smokes for 40 years. Dumps a lot of carcinogens 685 00:47:46,000 --> 00:47:50,000 into his lungs. The carcinogens which are highly, 686 00:47:50,000 --> 00:47:55,000 which induce mutations very potently are passed from his lungs into his 687 00:47:55,000 --> 00:48:00,000 blood and there go from the blood into the kidneys. 688 00:48:00,000 --> 00:48:04,000 And from the kidneys they are excreted into the urine and then 689 00:48:04,000 --> 00:48:09,000 they sit around in the bladder for a while. And let's imagine now that 690 00:48:09,000 --> 00:48:13,000 the urine of this man has all of these highly mutation-active 691 00:48:13,000 --> 00:48:18,000 carcinogens in his urine, which, in principle, can begin now 692 00:48:18,000 --> 00:48:23,000 to strike out and attack the genomes of the cells lining the urinary 693 00:48:23,000 --> 00:48:27,000 bladder. In other words, by, by smoking cigarettes you can 694 00:48:27,000 --> 00:48:32,000 actually mutate the genomes, somatic mutation, the genomes of 695 00:48:32,000 --> 00:48:37,000 cells lining the bladder of the, the urinary bladder, or, of course, 696 00:48:37,000 --> 00:48:41,000 to state the obvious, you can also mutate the genomes of the cells 697 00:48:41,000 --> 00:48:46,000 lining the alveoli in the lungs. That's why you get lung cancer. 698 00:48:46,000 --> 00:48:50,000 And a consequence of this can be, with serious probability, that now 699 00:48:50,000 --> 00:48:54,000 some of these cells become mutated and that, in turn, 700 00:48:54,000 --> 00:48:58,000 will lead to a life-threatening tumor. So, on this very cheerful 701 00:48:58,000 --> 00:49:02,000 note and your having heard two major take-home lessons, have 702 00:49:02,000 --> 00:49:07,000 a great weekend. See you on Monday. Enjoy 703 00:49:07,000 --> 00:49:12,000 the parade tomorrow.